Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial

…, J Douketis, D Wright, S Wikkerink, W Dechert… - The Lancet, 2018 - thelancet.com
Background Myocardial injury after non-cardiac surgery (MINS) increases the risk of
cardiovascular events and deaths, which anticoagulation therapy could prevent. Dabigatran …

Long-term (180-day) outcomes in critically ill patients with COVID-19 in the REMAP-CAP randomized clinical trial

…, L Poojara, T Sara, K Nand, B Reeve, W Dechert… - Jama, 2023 - jamanetwork.com
Importance The longer-term effects of therapies for the treatment of critically ill patients with
COVID-19 are unknown. Objective To determine the effect of multiple interventions for …

Effect of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker initiation on organ support–free days in patients hospitalized with COVID-19: a …

…, L Poojara, T Sara, K Nand, B Reeve, W Dechert… - Jama, 2023 - jamanetwork.com
IMPORTANCE Overactivation of the renin-angiotensin system (RAS) may contribute to poor
clinical outcomes in patients with COVID-19. Objective To determine whether angiotensin-…

Characteristics and outcomes of patients with COVID-19 admitted to hospital and intensive care in the first phase of the pandemic in Canada: a national cohort study

…, C Codan, N Daneman, W Dechert… - … Open Access Journal, 2021 - cmajopen.ca
Background: Clinical data on patients admitted to hospital with coronavirus disease 2019 (COVID-19)
provide clinicians and public health officials with information to guide practice and …

Effect of Antiplatelet Therapy on Survival and Organ Support–Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial

…, W Wittenberg, H Geurts, B Reeve, W Dechert… - JAMA, 2022 - jamanetwork.com
Importance The efficacy of antiplatelet therapy in critically ill patients with COVID-19 is uncertain.
Objective To determine whether antiplatelet therapy improves outcomes for critically ill …

Colchicine for Prevention of Perioperative Atrial Fibrillation in patients undergoing lung resection surgery: a pilot randomized controlled study

…, R Rodseth, S Pettit, W Dechert… - European Journal of …, 2018 - academic.oup.com
OBJECTIVES We carried out a pilot randomized controlled study to determine the feasibility
of a large trial evaluating the impact of colchicine versus placebo on postoperative atrial …

Intravenous vitamin C for patients hospitalized with COVID-19: two harmonized randomized clinical trials

…, L Poojara, T Sara, K Nand, B Reeve, W Dechert… - JAMA, 2023 - jamanetwork.com
Importance The efficacy of vitamin C for hospitalized patients with COVID-19 is uncertain.
Objective To determine whether vitamin C improves outcomes for patients with COVID-19. …

[HTML][HTML] Expanding the 3 Wishes Project for compassionate end-of-life care: a qualitative evaluation of local adaptations

…, J Hancock, S McMullen, B Reeve, W Dechert… - BMC palliative …, 2020 - Springer
Background The 3 Wishes Project (3WP) is an end-of-life program that honors the dignity of
dying patients by fostering meaningful connections among patients, families, and clinicians. …

[HTML][HTML] Community implementation of the 3 Wishes Project: an observational study of a compassionate end-of-life care initiative for critically ill patients

BK Reeve, BB Dennis, W Dechert, B Longo… - … Open Access Journal, 2021 - cmajopen.ca
Background: The 3 Wishes Project (3WP) promotes a personalized dying experience by
eliciting and facilitating individualized terminal wishes for patients, families and the clinicians …

[PDF][PDF] A multi-country analysis of COVID-19 hospitalizations by vaccination status

…, F D'Aragon, C De Rose, T de Silva, W Dechert… - Med, 2023 - cell.com
Background Individuals vaccinated against severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2), when infected, can still develop disease that requires hospitalization. It …